CRIS Current Research Information System

FIORINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.148
NA - Nord America 4.439
EU - Europa 3.450
SA - Sud America 308
AF - Africa 139
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.367
SG - Singapore 1.510
IT - Italia 1.261
CN - Cina 1.235
VN - Vietnam 1.208
GB - Regno Unito 528
HK - Hong Kong 409
DE - Germania 328
SE - Svezia 323
BR - Brasile 238
FR - Francia 213
IN - India 183
RU - Federazione Russa 159
KR - Corea 146
IE - Irlanda 138
NL - Olanda 128
BD - Bangladesh 91
JP - Giappone 87
UA - Ucraina 84
JO - Giordania 75
FI - Finlandia 63
ZA - Sudafrica 63
CA - Canada 41
BG - Bulgaria 40
EE - Estonia 36
ID - Indonesia 32
AT - Austria 24
AR - Argentina 23
PH - Filippine 23
IQ - Iraq 22
TH - Thailandia 21
CI - Costa d'Avorio 20
MX - Messico 20
TR - Turchia 20
ES - Italia 19
CH - Svizzera 18
TW - Taiwan 18
BE - Belgio 17
EC - Ecuador 16
MY - Malesia 13
PK - Pakistan 13
SC - Seychelles 13
PY - Paraguay 10
PL - Polonia 9
GR - Grecia 8
HR - Croazia 8
SA - Arabia Saudita 8
CO - Colombia 7
MA - Marocco 7
RO - Romania 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
EG - Egitto 6
TG - Togo 6
UZ - Uzbekistan 6
AL - Albania 5
AU - Australia 5
LB - Libano 5
RS - Serbia 5
DK - Danimarca 4
KE - Kenya 4
LK - Sri Lanka 4
LT - Lituania 4
PE - Perù 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
PT - Portogallo 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CD - Congo 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
Totale 13.483
Salva come PNG Salva come JPEG
Città #
Singapore 1.029
Ashburn 475
Southend 455
Hong Kong 389
Hefei 328
Chandler 306
Ho Chi Minh City 285
San Jose 283
Fairfield 277
Santa Clara 271
Hanoi 241
Bologna 154
Woodbridge 151
Princeton 144
Dublin 137
Beijing 135
Seoul 134
Wilmington 129
Dong Ket 125
Houston 122
Boardman 121
Milan 120
Seattle 116
Cambridge 104
Ann Arbor 101
Lauterbourg 92
Los Angeles 89
Council Bluffs 86
New York 85
Amman 75
Rome 75
Tokyo 62
Buffalo 54
Westminster 52
Da Nang 49
Helsinki 45
Nanjing 45
Padova 45
Jacksonville 44
Berlin 43
Redmond 40
Sofia 40
Jinan 37
São Paulo 35
Turin 35
Haiphong 33
Dallas 32
Tappahannock 31
Bengaluru 30
Redondo Beach 30
Guangzhou 28
Naples 25
Parma 23
Des Moines 22
Frankfurt am Main 22
Shanghai 22
Shenyang 22
Biên Hòa 21
Abidjan 20
Changsha 20
San Diego 19
Nuremberg 18
Munich 17
Tianjin 17
Yubileyny 17
Bari 16
Brussels 16
Hebei 16
Jakarta 16
Moscow 16
Rimini 16
Saint Petersburg 16
Chicago 15
Johannesburg 15
Florence 14
Lappeenranta 14
Mülheim 14
Phoenix 14
San Francisco 14
Zhengzhou 14
Dearborn 13
Hangzhou 13
Hải Dương 13
Nanchang 13
Verona 13
Amsterdam 12
Montreal 12
Shenzhen 12
Bangkok 11
Frattamaggiore 11
London 11
Nakano 11
Rovigo 11
Vienna 11
Can Tho 10
Norwalk 10
Atlanta 9
Brooklyn 9
Bến Tre 9
Catania 9
Totale 8.178
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 584
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 388
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 270
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 223
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 208
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 199
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 194
Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study. 193
Gastroesophageal Reflux Disease and Barrett’s Esophagus 189
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 182
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 181
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 177
Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure 173
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 170
Therapy for H. pylori: Current concepts 169
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 168
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 168
In vivo dissolution of levothyroxine soft gel capsules 168
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? 167
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 164
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 164
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 161
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 158
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 156
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 156
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 154
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 152
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 150
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 150
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 149
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol 147
Diagnosi dell'infezione da Helicobacter pylori 147
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels 145
Probiotici ricombinanti e loro potenziale sulla salute umana 144
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 143
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 141
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 139
Recombinant probiotics and their potential in human health 139
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 137
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 137
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 136
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 136
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 133
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 132
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 131
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 130
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 128
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 127
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 125
Nephrotic Range Proteinuria and Acute Heart Failure 125
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 123
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 122
Expanding Cancer Prevention: Strategies Integrated into Occupational Health Surveillance 121
Diagnostic yield of upper endoscopy according to appropriateness: A systematic review 121
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 121
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 120
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 120
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 115
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 114
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 113
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 111
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 111
Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation 108
Role of Helicobacter Pylori Infection in the Thyroid Diseases 107
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 105
New strategies for the treatment of hyperkalemia. 104
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis 104
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale 103
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients 102
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 101
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 101
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 100
The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review 100
Diverticulosis, Adenomas, and Cancer in the Colon A Systematic Review and Meta-Analysis of Endoscopic Studies 99
Sequential therapy for first-line helicobacter pylori eradication: 10- or 14-day regimen? 98
Whipple’s Disease: Case Report and Review of the Literature 97
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 95
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 94
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 94
Newer agents for Helicobacter pylori eradication 90
Helicobacter pylori: la nuova terapia. 87
Paradigm shift: The copernican revolution in diverticular disease 86
Comparative Evaluation of Tongue and Periodontal Pocket Microbiome in Relation to Helicobacter pylori Gastric Disease: 16S rRNA Gene Sequencing Analysis 86
Rescue Therapies for H. pylori Infection in Italy 85
null 83
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 83
Understanding the epidemiology of gastric cancer: A review and case-only analysis from Italy 81
null 81
Lung ultrasound in the COVID-19 era: a lesson to be learned for the future 78
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 78
Gestione del paziente, diagnostica rapida, nuove terapie per l’infezione da Helicobacter pylori. 78
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study 77
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? 76
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 74
Is the First Cut Always the Deepest? 73
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 73
Helicobacter Pylori infection in psoriatic patients during biological therapy 72
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 69
Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study 68
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 62
Totale 13.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 0 0 0 0 0 0 223
2021/20221.194 114 40 58 123 125 44 27 86 42 31 333 171
2022/20231.375 118 140 89 160 77 110 55 92 314 70 93 57
2023/2024719 45 123 49 83 39 96 39 40 23 65 66 51
2024/20252.432 107 356 194 169 392 145 161 95 50 102 143 518
2025/20265.670 413 513 461 432 585 358 696 232 1.059 463 256 202
Totale 13.734